Environmental Sustainability In Medicines Using Natural Ingredients In Uae
DOI:
https://doi.org/10.64252/1e01jf51Keywords:
Environmental Sustainability, Green Chemistry, Natural Products, Green Synthesis, Sustainable Bioprocessing, Pharmaceuticals, UAE Drug Policy, Green Hospitals, Natural‐Ingredient Medicine.Abstract
Environmental sustainability is an increasingly critical focus in the global pharmaceutical sector, driven by growing concerns over pollution from drug manufacturing, improper disposal, and the ecological footprint of synthetic compounds. Concurrently, advances in green chemistry and sustainable bioprocessing—such as supercritical fluid extraction, ultrasound-assisted extraction, microwave-assisted extraction, and plant-mediated green synthesis—offer eco-friendly pathways for the development of biocompatible, biodegradable, and non-toxic natural-product–based therapeutics. Although the UAE has demonstrated robust commitments to sustainability—through national frameworks promoting green hospitals and strengthening local pharmaceutical production under its national drug policy—existing research has yet to thoroughly examine the integration of natural-ingredient usage in drug development as a strategy for environmental sustainability in the Emirati context. This study aims to bridge that gap by mapping existing UAE-based research and policy concerning sustainable pharmaceutical practices, exploring the adoption of natural ingredients and green synthesis methodologies, and identifying institutional and regulatory enablers and obstacles. Drawing on systematic literature review and policy analysis, the research delineates the opportunities presented by natural bioactive compounds and emerging green technologies, in alignment with UAE sustainability goals. The findings aim to inform future biopharmaceutical research, encourage collaborations between institutions like the International Centre for Bio-saline Agriculture and local R&D ecosystems, and support the embedding of green natural-ingredient strategies within national drug development pathways. This study not only provides foundational insights for sustainable medicine innovation in the UAE but also offers a potential blueprint for broader sustainable healthcare development across arid-region contexts.